JDRF Funding Opportunity: Beta Cell Regeneration and Survival Innovative Grants
JDRF provides seed funding for highly innovative research with significant potential to accelerate the mission of JDRF. JDRF’s Beta Cell Regeneration and Survival research priority areas include (1) Beta cell survival therapy (2) Beta cell regeneration therapy (3) Biomarkers and clinical path initiatives. Application deadline: Oct. 31, 2018.
IDG-DREAM Drug Kinase Binding Prediction Challenge
This IDG-DREAM Drug-Kinase Binding Prediction Challenge seeks to evaluate the power of statistical and machine learning models as a systematic and cost-effective means for catalyzing compound-target interaction mapping efforts by prioritizing most potent interactions for further experimental evaluation. The Challenge will focus on kinase inhibitors, due to their clinical importance, toward extending the druggability of the human kinome space. The challenge will run through the fall of 2018.
Funding Opportunities: The Chan Zuckerberg Initiative Imaging Scientist
The Chan Zuckerberg Initiative (CZI) seeks to support up to 10 Imaging Scientists who will work at the interface of biology, microscopy hardware, and imaging software at imaging centers across the United States. The award period is three years plus an additional two years if the Imaging Program passes a review at year three. Application due date: Oct. 3, 2018.
The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant 2U24DK097771-06.